Alexion Pharmaceuticals Inc. (ALXN)

BiotechnologyHealthcare

105.26-3.29(-3.03%)

26/01/2020 19:13:54


52 Week L/H
94.84
141.3

ALXN Stock Price Chart


Fundamental ratios

Price-to-Earnings Ratio (TTM)
16.9
Price-to-Earnings Ratio (5 year avg)
38.0
Enterprise-value-to-EBITDA ratio
20.98
Price-to-book ratio
2.36
Price/Earnings-to-Growth Ratio
0.19
EV/Invested Capital
24,919 Million

Profitability ratios

Return on Invested Capital
12.1
Return on Invested Capital average (5y)
6.72
Return on Equity
0.32
Return on Equity average (5y)
6.4
Return on Assets
0.14
Return on Assets average (5y)
4.72

Growth rates

Revenue growth
Revenue growth 5y CAGR
13.09
EBITDA growth
0.0
EBITDA 5y CAGR
-4.16
Net Income growth
0.0
Net Income 5y CAGR

Stock Margins

Gross Margin
92.0
Gross Margin Average (5y)
93.26
EBITDA Margin
42.4
EBITDA Margin Average (5y)
30.71
Net Margin
151.1
Net Margin average (5y)
22.22

Risk and leverage

Max. Drawdown 5yNA
Return over Max Drawdown (5y)-0.76%
Max. Drawdown since GR-54.8%
Return over Max D. Since GR
Debt to Equity
0.26
Interest Coverage Ratio
20.2

Dividends and its sustainability

Dividend Yield
NA
Dividend per share
NA
DPS 5y CAGR
NA
Dividend payout ratio
0.0
Dividend to FCF
NA
Payout Ratio
0.0

Basic Information

Earnings per Share (EPS)
6.57
EPS Estimate Currrent Qtr
2.33
Book Value Per Share
46.85
Market Cap
24,435 Million
PE Ratio
16.9
Enterprise Value
24,919 Million
Invested Capital
49,219 Million

Stock Yield

Stock Return 7 Days -6.85%
Stock Return 15 Days-7.59%
Stock Return 30 Days-3.02%
Stock Return 3 Months-1.21%
Stock Return One Year-11.69%
Stock Return 3 Years-17.89%

Note: Calculations based on previous day's adjusted closing prices

Stock Technical Analysis

Relative Strengh Index (14)
37.74
Momentum (14)
1.14
Simple Moving Average (14)
110.39
Exponential Moving Average (14)
110.16
Average True Range
3.1

Note: Calculations based on previous day's adjusted closing prices